Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

105987

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pneumococcal Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate he has made of the number of cases of invasive pneumococcal disease which were preventable in each of the last five years.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	213013
	answer	answer is ministerial correction date of answer 06/11/2014 answer text <p>Data for England and Wales are analysed six months after the end of the reporting year based on laboratory confirmed reports of invasive pneumococcal disease (IPD) and the results of serotyping.</p><p> </p><p> </p><p> </p><p>The data provided below relates to the total number of IPD cases in England and Wales for all ages up to June 2013 with serotypes that are in the current Pneumococcal Conjugate Vaccine-13 (PCV-13) vaccine recommended in the childhood schedule and which are potentially preventable. PCV-13, which was introduced in 2010, is routinely offered to children aged two, four and 12 months.</p><p> </p><p> </p><p> </p><p>Number of IPD cases for all ages, up to June 2013:</p><p> </p><p> </p><p> </p><table><thead><tr><td><p>Year</p></td><td><p>Number of IPD cases</p></td></tr></thead><tbody><tr><td><p>2008-09</p></td><td><p>3,049</p></td></tr><tr><td><p>2009-10</p></td><td><p>2,759</p></td></tr><tr><td><p>2010-11</p></td><td><p>2,690</p></td></tr><tr><td><p>2011-12</p></td><td><p>1,768</p></td></tr><tr><td><p>2012-13</p></td><td><p>1,448</p></td></tr></tbody></table><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/11/2014 17:27:10 answering member 3918 label Biography information for Jane Ellison
	tabling member	308 label Biography information for Mr Jim Cunningham

105989

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pneumococcal Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure that his Department's pneumococcal vaccination targets are met.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	213012
	answer	answer is ministerial correction date of answer 06/11/2014 answer text <p>Immunisation against pneumococcal disease is offered to children at two, four and 12-13 months of age, and adults aged 65 years or over. It is also recommended to those at increased risk of pneumococcal infection.</p><p> </p><p> </p><p> </p><p>There are no targets set for the pneumococcal programmes. The need to aim for as high an uptake rate as possible is set out in the Section 7A service agreement between the Department and NHS England for each individual vaccination programme. This agreement states that the objectives of the programme concerned is to improve or at least maintain the vaccination coverage from the previous year’s annual uptake results.</p><p> </p><p> </p><p> </p><p>Vaccinating risk groups is now in the general practitioners (GPs) contract and GP practices have systems to ensure eligible patients are invited for vaccine to improve coverage.</p><p> </p><p> </p><p> </p><p>Leaflets and other promotional material explaining the benefits of pneumococcal immunisation are produced by Public Health England (PHE) for the use of GPs and other health professionals. Information about this immunisation is also available on the NHS Choices and PHE websites.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/11/2014 17:40:07 answering member 3918 label Biography information for Jane Ellison
	tabling member	308 label Biography information for Mr Jim Cunningham

102045

	registered interest
	date	31/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Meningitis: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the reasons are for the time taken to conclude negotiations for a price for including the vaccine for meningitis B in the national immunisation programme; and when those negotiations will be completed.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	212858
	answer	answer is ministerial correction date of answer 05/11/2014 answer text <p>The Department is continuing negotiations for the supply of the meningococcal B vaccine Bexsero<sup>®</sup> with the manufacturer Novartis.</p><p> </p><p> </p><p> </p><p>It would not be appropriate to comment on these commercial negotiations, which will be completed as quickly as practicable.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 05/11/2014 15:50:50 answering member 3918 label Biography information for Jane Ellison
	tabling member	308 label Biography information for Mr Jim Cunningham

105985

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pneumococcal Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what proportion of people in defined at risk groups who were eligible for pneumococcal vaccinations were vaccinated against pneumococcal disease in each of the last five year for which figures are available.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	213014
	answer	answer is ministerial correction date of answer 06/11/2014 answer text <p>The following tables show the percentage who received the pneumococcal vaccinations (PPV) in that financial year, and the percentage of people 65 years and over who have ever received PPV vaccine.</p><p> </p><p> </p><p> </p><p>Percentage of those aged 65 years+ vaccinated against PPV in each of last five years:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Period vaccinated</p></td><td><p>Percentage of &gt;=65 years received PPV vaccine</p></td><td><p> </p></td><td><p>Period vaccinated</p></td><td><p>Percentage of &gt;=65 years received PPV vaccine</p></td></tr><tr><td><p>From 1 April 2008 to 31 March 2009</p></td><td><p>4.1%</p></td><td><p> </p></td><td><p>Anytime up to 31 March 2009</p></td><td><p>68.2%</p></td></tr><tr><td><p>From 1 April 2009 to 31 March 2010</p></td><td><p>3.9%</p></td><td><p> </p></td><td><p>Anytime up to 31 March 2010</p></td><td><p>69.4%</p></td></tr><tr><td><p>From 1 April 2010 to 31 March 2011</p></td><td><p>3.8%</p></td><td><p> </p></td><td><p>Anytime up to 31 March 2011</p></td><td><p>70.5%</p></td></tr><tr><td><p>From 1 April 2011 to 31 March 2012</p></td><td><p>3.6%</p></td><td><p> </p></td><td><p>Anytime up to 31 March 2012</p></td><td><p>68.3%</p></td></tr><tr><td><p>From 1 April 2012 to 31 March 2013</p></td><td><p>3.9%</p></td><td><p> </p></td><td><p>Anytime up to 31 March 2013</p></td><td><p>69.1%</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>There has only been one survey of pneumococcal vaccine uptake for clinical risk groups under 65 years of age which was undertaken in 2009. The proportion who had received vaccine in the financial year (1 April 2008 to 31 March 2009) was 3.7%. The cumulative vaccine uptake for those in a clinical at risk group aged 2 to 65 years up and until 31 March 2009 (i.e. those who had received pneumococcal vaccine at any time up to that date) was 53.0%.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/11/2014 17:31:16 answering member 3918 label Biography information for Jane Ellison
	tabling member	308 label Biography information for Mr Jim Cunningham

105984

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pneumococcal Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what proportion of people have records contained in the General Practice Research Database; how many patients whose records are in the Database have at least one record of pneumococcal disease (a) in total and (b) in the last year for which figures are available; and if he will make a statement.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	213015
	answer	answer is ministerial correction date of answer 06/11/2014 answer text <p>The main primary care database held by the Clinical Practice Research Datalink (CPRD) is known as CPRD GOLD (formerly known as the General Practice Research Database, or GPRD). CPRD GOLD contains the anonymised, longitudinal medical records of patients registered with contributing primary care practices across the United Kingdom.</p><p> </p><p> </p><p> </p><p>The CPRD GOLD database covers approximately 8.8% of the UK population, including practices in England, Northern Ireland, Scotland and Wales. As of September 2014 there were 684 general practitioner (GP) practices and 13.58 million acceptable (research quality) patients in GOLD, of which 5.69 million are active (still alive and registered with the GP practice). Data has been collected from GP practices since 1987.</p><p> </p><p> </p><p> </p><p>A review of the CPRD GOLD database has identified the a total of 15,248 acceptable (research quality) patients with at least one record of pneumococcal disease in CPRD GOLD over the period 1 January 1987 to 30 September 2014 during their up-to-standard registration period. Of these patients, 14,150 had at least one record of pneumococcal pneumonia and 491 patients had at least one record of pneumococcal meningitis.</p><p> </p><p> </p><p> </p><p>Over the period 1 October 2013 to 30 September 2014, there were a total of 473 acceptable (research quality) patients with at least one record of pneumococcal disease during their up-to-standard registration period. Of these patients; 445 had a record of pneumococcal pneumonia and 14 had at least one record of pneumococcal meningitis.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 06/11/2014 13:15:07 answering member 4020 label Biography information for George Freeman
	tabling member	308 label Biography information for Mr Jim Cunningham

105988

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pneumococcal Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the cost to the NHS was of treating invasive pneumococcal disease in each year from 2008 to 2013.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	213011
	answer	answer is ministerial correction date of answer 06/11/2014 answer text <p>We are advised that NHS England does not hold estimates of the cost of treating invasive pneumococcal disease covering the years from 2008-2013.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/11/2014 13:07:52 answering member 3918 label Biography information for Jane Ellison
	tabling member	308 label Biography information for Mr Jim Cunningham